ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260273.1	Motesanib	Colon adenocarcinoma	0.043150965	Resistant
ENSG00000260273.1	Motesanib	Lung squamous cell carcinoma	0.025940023	Sensitive